213 related articles for article (PubMed ID: 6410985)
1. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
2. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
3. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
Minukhin VV; Tsyganenko VIa
Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
Minukhin VV; Tsyganenko AIa
Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):90-2. PubMed ID: 3098009
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection].
Vetkova LG; Antsiferova NG; Radkevich SA; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):51-6. PubMed ID: 3922187
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Minukhin VV; Tsyganenko AIa
Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
[TBL] [Abstract][Full Text] [Related]
7. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
8. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
9. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
Minukhin VV; Tsyganenko AIa
Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
[TBL] [Abstract][Full Text] [Related]
10. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
[No Abstract] [Full Text] [Related]
11. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
Chusid MJ; Davis SD; Sarff LD
J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa infection: pathogenesis and therapy.
Pennington JE
Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
[No Abstract] [Full Text] [Related]
13. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
[No Abstract] [Full Text] [Related]
14. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
[TBL] [Abstract][Full Text] [Related]
15. [Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa].
Shcherbakova EG; Medvedeva MM; Rastunova GA; Sobolev VR
Antibiotiki; 1975; 20(12):1112-5. PubMed ID: 817650
[No Abstract] [Full Text] [Related]
16. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
Meitert E; Meitert T; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
[No Abstract] [Full Text] [Related]
17. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
Okada K; Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
[TBL] [Abstract][Full Text] [Related]
18. [Experimental vaccinal prophylaxis of Pseudomonas aeruginosa burn sepsis].
Bandman OA; Stanislavskiĭ ES; Kholodkova EV; Ivanova TV; Salov VF
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):59-62. PubMed ID: 2510430
[TBL] [Abstract][Full Text] [Related]
19. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
[No Abstract] [Full Text] [Related]
20. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
Toama MA; Hamed IM; Ashour SM
Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
